Lisa Wilson | Investor Relations |
Hugh O’Dowd | Chief Executive Officer |
James D’Arecca | Chief Financial Officer |
Mark Glickman | Chief Business Officer |
Louise Chen | Cantor Fitzgerald |
Douglas Tsao | H.C. Wainwright |
0:05 Good morning, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD Fourth Quarter 2021 Financial Results conference call.
Following prepared remarks from the company, we will open the call for questions. 0:18 I would now like to turn the call over to Investor Relations for TherapeuticsMD. Lisa Wilson.